Samik Basu
Company: Cabaletta Bio
Job title: Chief Scientific Officer
Seminars:
Mechanistic Insights of CABA-201 in Autoimmune Disease 11:00 am
• Clinical safety and efficacy of CABA-201 across different autoimmune diseases • Translational data highlighting the mechanism of action of CABA-201 NEW DATARead more
day: Day Two Track B, AM
Industry Leader’s Fireside Chat: Exploring Present Advancements & Challenges in the Cell Therapies for Autoimmune Disease Space 8:30 am
An interactive panel discussion from the industry leaders to set the scene on the autoimmune space. Ask your questions live to understand the expert’s thoughts on key topics including: • How has this rapidly evolving space advanced this year? • Discussing the latest findings and what this means for the cell therapy for autoimmune field…Read more
day: Day One AM